Charlie Balme > Marks & Clerk > London, England > Lawyer Profile

Clients ranging from start-ups and universities to the likes of Gilead and AstraZeneca turn to the patent prosecution team at Marks & Clerk for assistance with work such as patent revocation actions, patent portfolio due diligence and EPO opposition matters. Mike Gilbert heads up the team alongside Will Nieuwenhuys. Gilbert’s practice combines high-profile patent litigation and matters concerning Supplementary Protection Certificates, while Nieuwenhuys is known for his expertise in small molecule organic and pharmaceutical chemistry. Charlie Balme is equipped to handle litigation, arbitration and commercial IP matters connected to medical devices.

With expertise across hi-tech, software, and manufacturing sectors, to name a few, Marks & Clerk‘s technical capabilities enable it to operate for pharmaceutical and biotech companies that hold established global presences. Life sciences expert Mike Gilbert, who has handled a range of revocation, infringement, and declaration proceedings, and litigator Dafydd Bevan, who handles a plethora of mechanical, electronic, software, and telecoms mandates, jointly helm the group. Charlie Balme is especially knowledgeable in the field of biopharma patent litigation, while Daniel McGrath is noted for his ability to handle technical patent and SPC litigation.